FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular, to otorhinolaryngology, and can be used for treating patients with purulent rhinosinusites with concomitant type 2 diabetes mellitus. The method includes additional prescription of therapy with sodium deoxyribonucleate (derinate) at a dose of 6 mg intramuscularly according to the following regimen: 5 injections every other day, then 5 injections 2 times a week, to patients with rhinosinusitis accompanied by type 2 diabetes mellitus.
EFFECT: use of the invention allows for a reduction in the duration of treatment, a more stable and prolonged remission, a decrease in the blood sugar levels and the risk of developing complications of the disease.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EVALUATING THE EFFICIENCY OF MEDICAMENTAL THERAPY OF ACUTE EXACERBATIONS OF CHRONIC PURULENT SINUSITIS | 2015 |
|
RU2600645C2 |
| METHOD FOR PREDICTING DEVELOPMENT OF OTITIS MEDIA IN PATIENTS WITH RHINOSINUSITIS | 2020 |
|
RU2750024C1 |
| METHOD OF TREATING PATIENTS WITH RHINOSINUSITIS | 2014 |
|
RU2580657C1 |
| METHOD FOR TREATING PATIENTS WITH ALLERGIC RHINITIS ASSOCIATED WITH CHRONIC RHINOSINUSITIS OF BACTERIAL ETIOLOGY USING A DOMESTICALLY PRODUCED TOPICAL IMMUNE CORRECTOR | 2020 |
|
RU2760825C1 |
| METHOD OF TREATING PATIENTS WITH RHINOSINUSITIS | 2014 |
|
RU2564006C1 |
| METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
| METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2009 |
|
RU2408385C1 |
| METHOD FOR DETERMINING DEGREE OF RHINOSINUSITIS SEVERITY | 2015 |
|
RU2611389C1 |
| METHOD FOR DETECTING GENOTYPES PREDISPOSING RECURRENCE OF NASAL POLYPS IN PATIENTS WITH POLYPOUS SINUSITIS | 2020 |
|
RU2741930C1 |
| METHOD OF CLINICAL EFFECTIVENESS IN PATIENTS WITH CHRONIC CONDITIONS OF NOSE AND ACCESSORY SINUSES OF NOSE | 2010 |
|
RU2431834C1 |
